Park Avenue Securities’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-3,631
Closed -$230K 1461
2024
Q3
$230K Sell
3,631
-476
-12% -$34.4K ﹤0.01% 1291
2024
Q2
$277K Sell
4,107
-12
-0.3% -$838 ﹤0.01% 1217
2024
Q1
$326K Buy
4,119
+25
+0.6% +$2.04K ﹤0.01% 1142
2023
Q4
$318K Sell
4,094
-404
-9% -$29.9K ﹤0.01% 1100
2023
Q3
$316K Buy
+4,498
New +$336K ﹤0.01% 1018
2023
Q1
Sell
-5,085
Closed -$419K 698
2022
Q4
$419K Sell
5,085
-82
-2% -$6.76K 0.01% 850
2022
Q3
$404K Sell
5,167
-1,366
-21% -$109K 0.01% 796
2022
Q2
$442K Sell
6,533
-2,413
-27% -$168K 0.01% 749
2022
Q1
$586K Sell
8,946
-486
-5% -$28.2K 0.01% 676
2021
Q4
$572K Sell
9,432
-775
-8% -$46.2K 0.01% 655
2021
Q3
$651K Buy
10,207
+276
+3% +$17.4K 0.01% 547
2021
Q2
$623K Buy
9,931
+683
+7% +$42.8K 0.01% 552
2021
Q1
$528K Buy
9,248
+3,712
+67% +$201K 0.01% 569
2020
Q4
$278K Buy
+5,536
New +$221K 0.01% 718

Other funds holding ACHC

Park Avenue Securities's ACHC Position: Q4 2024 in Review

Park Avenue Securities sold out of Acadia Healthcare (ACHC) in Q4 2024, closing a stake of 3,631 shares — an estimated $230K sold.

Park Avenue Securities first reported a position in ACHC in Q4 2020 and held it in 14 quarters. The position peaked at $651K in Q3 2021. 306 funds tracked by Wall St. Rank hold ACHC as of Q4 2024.

  • Park Avenue Securities reported no remaining Acadia Healthcare position as of Q4 2024 after selling out during the quarter.
  • Park Avenue Securities sold 3,631 Acadia Healthcare shares in Q4 2024, an estimated $230K.
  • Park Avenue Securities first reported a position in Acadia Healthcare in Q4 2020 and held it in 14 quarters.
  • Park Avenue Securities's Acadia Healthcare position peaked at $651K in Q3 2021.
  • 306 funds tracked by Wall St. Rank held Acadia Healthcare as of Q4 2024.

Based on Park Avenue Securities's 13F filing for Q4 2024, filed 14 Jan 2025.